Gill Pearce

546 total citations
3 papers, 375 citations indexed

About

Gill Pearce is a scholar working on Infectious Diseases, Virology and Pharmacology. According to data from OpenAlex, Gill Pearce has authored 3 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 2 papers in Virology and 1 paper in Pharmacology. Recurrent topics in Gill Pearce's work include HIV/AIDS drug development and treatment (3 papers), HIV Research and Treatment (2 papers) and Drug-Induced Adverse Reactions (1 paper). Gill Pearce is often cited by papers focused on HIV/AIDS drug development and treatment (3 papers), HIV Research and Treatment (2 papers) and Drug-Induced Adverse Reactions (1 paper). Gill Pearce collaborates with scholars based in United States, United Kingdom and Italy. Gill Pearce's co-authors include Amy Cutrell, Helen Steel, Seth Hetherington, Odin Naderer, Peré Domingo, Renato Maserati, Georg M. N. Behrens, Armin Rieger, Hui Wang and Florian Abel and has published in prestigious journals such as Clinical Therapeutics, Current Medical Research and Opinion and Antiviral Therapy.

In The Last Decade

Gill Pearce

3 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gill Pearce United States	3	182	166	126	77	65	3	375
Trevor R. Scott United States	10	342 1.9×	162 1.0×	257 2.0×	74 1.0×	61 0.9×	12	615
Helen Steel United Kingdom	10	305 1.7×	234 1.4×	208 1.7×	74 1.0×	95 1.5×	12	626
Denise Sutherland‐Phillips United States	7	493 2.7×	273 1.6×	374 3.0×	195 2.5×	108 1.7×	13	827
Cynthia H. Brothers United States	4	188 1.0×	58 0.3×	140 1.1×	40 0.5×	26 0.4×	6	292
Cassidy Henegar United States	10	162 0.9×	40 0.2×	55 0.4×	56 0.7×	27 0.4×	28	269
Debra Ogata-Arakaki United States	10	214 1.2×	31 0.2×	91 0.7×	85 1.1×	30 0.5×	13	437
Gema González‐Pardo Spain	7	348 1.9×	31 0.2×	169 1.3×	112 1.5×	10 0.2×	9	454
Ricky Hsu United States	9	161 0.9×	30 0.2×	85 0.7×	92 1.2×	8 0.1×	20	255
Geoffrey Kabuye Uganda	4	108 0.6×	33 0.2×	73 0.6×	18 0.2×	15 0.2×	5	154
Clotilde Le Tiec France	8	330 1.8×	17 0.1×	216 1.7×	66 0.9×	8 0.1×	10	432

Countries citing papers authored by Gill Pearce

Since Specialization

Citations

This map shows the geographic impact of Gill Pearce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gill Pearce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gill Pearce more than expected).

Fields of papers citing papers by Gill Pearce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gill Pearce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gill Pearce. The network helps show where Gill Pearce may publish in the future.

Co-authorship network of co-authors of Gill Pearce

This figure shows the co-authorship network connecting the top 25 collaborators of Gill Pearce. A scholar is included among the top collaborators of Gill Pearce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gill Pearce. Gill Pearce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Behrens, Georg M. N., Renato Maserati, Armin Rieger, et al.. (2012). Switching to Tenofovir/Emtricitabine from Abacavir/ Lamivudine in HIV-Infected Adults with Raised Cholesterol: Effect on Lipid Profiles. Antiviral Therapy. 17(6). 1011–1020. 41 indexed citations

2.

Vibhagool, Asda, Pedro Cahn, Mauro Schechter, et al.. (2004). Triple nucleoside treatment with abacavir plus the lamivudine/ zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: results of a 48-week open-label, equivalence trial (CNA3014). Current Medical Research and Opinion. 20(7). 1103–1114. 35 indexed citations

3.

Hetherington, Seth, et al.. (2001). Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir. Clinical Therapeutics. 23(10). 1603–1614. 299 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact